October 29, 2010 (New York, New York) — Pfizer is recalling two additional lots of atorvastatin (Lipitor) 40 mg, or approximately 38 000 bottles, because of "customer reports of an uncharacteristic odor related to the bottles in which these lots of Lipitor were packaged. [1]"

Earlier this month, Pfizer reported that it had recalled seven lots of atorvastatin for the same reason.

Like the earlier recall, the company said the odor is consistent with the presence of 2,4,6 tribromoanisole (TBA), which was found at low levels in one of the complaint sample bottles during the first recall. The plastic bottles are sourced from a third party, according to Pfizer.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.
Post as: